共 50 条
- [1] Aspirin and low-dose rivaroxaban - the dual pathway concept in patients with stable atherosclerotic disease: a comprehensive reviewEXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (09) : 577 - 585Parascandolo, EliotEisen, Alon
- [2] Pharmacodynamic profiles of aspirin versus dual-pathway inhibition with either aspirin or clopidogrel among patients with stable atherosclerotic diseaseEUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G24 - +Galli, MattiaFranchi, FrancescoRollini, FabianaBeen, LatonyaJaoude, PatrickRivas, AndreaZhou, XuanJia, SidaMaaliki, NajiLee, ChangPineda, AndresSuryadevara, SivaSoffer, DanielZenni, MartinJennings, LisaBass, TheodoreAngiolillo, Dominick J.
- [3] Pharmacodynamic profiles of aspirin versus dual-pathway inhibition with either aspirin or clopidogrel among patients with stable atherosclerotic diseaseEUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)Galli, MattiaFranchi, FrancescoRollini, FabianaBeen, LatonyaJaoude, PatrickRivas, AndreaZhou, XuanJia, SidaMaaliki, NajiLee, ChangPineda, AndresSuryadevara, SivaSoffer, DanielZenni, MartinJennings, LisaBass, TheodoreAngiolillo, Dominick J.
- [4] Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic DiseaseTHROMBOSIS AND HAEMOSTASIS, 2022, 122 (08) : 1341 - 1351Galli, MattiaFranchi, FrancescoRollini, FabianaBeen, LatonyaAbou Jaoude, PatrickRivas, AndreaZhou, XuanJia, SidaMaaliki, NajiLee, Chang HoonPineda, Andres M.Suryadevara, SivaSoffer, DanielZenni, Martin M.Geisler, TobiasJennings, Lisa K.Bass, Theodore A.Angiolillo, Dominick J.
- [5] COMPARING THE CLINICAL BENEFIT OF LOW-DOSE RIVAROXABAN PLUS ASPIRIN TO DUAL ANTIPLATELET THERAPY (DAPT) IN PATIENTS WITH CHRONIC ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)ATHEROSCLEROSIS, 2024, 395Shengelia, TamarNadaraia, KakhaKvitsaridze, Besik
- [6] DUAL PATHWAY INHIBITION USING LOW DOSE RIVAROXABAN PLUS LOW DOSE ASPIRIN IN PATIENTS WITH CARDIOVASCULAR DISEASE: A META-ANALYSISJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1690 - 1690Sibbing, DirkBlaha, Michael J.Kishore, AmitLanas, AngelLi, LiSantilli, FrancescaShi, ZhongweiVardar, Burcu
- [7] Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot StudyFRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9Jurk, KerstinRothenaicher, Korbinian F.Gross, KathrinRossmann, HeidiWeisser, GerhardSchmidtmann, IreneMuenzel, ThomasEspinola-Klein, Christine
- [8] Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery DiseaseCardiology and Therapy, 2024, 13 : 233 - 242Laszlo A. GrohLoes H. WillemsPaula FintelmanMichel M. P. J. ReijnenSaloua El MessaoudiMichiel C. Warlé
- [9] Dual-Pathway Inhibition with Rivaroxaban and Low-Dose Aspirin Does Not Alter Immune Cell Responsiveness and Distribution in Patients with Coronary Artery DiseaseCARDIOLOGY AND THERAPY, 2024, 13 (01) : 233 - 242Groh, Laszlo A.Willems, Loes H.Fintelman, PaulaReijnen, Michel M. P. J.El Messaoudi, SalouaWarle, Michiel C.
- [10] Low-Dose Rivaroxaban vs. Aspirin in Addition to Clopidogrel After Percutaneous Coronary Intervention in Coronary Atherosclerotic Heart Disease Patients with Gastrointestinal DiseaseCARDIOVASCULAR DRUGS AND THERAPY, 2025,Li, YueZhou, TienanLiu, YanQi, JunxianZhang, LeiGu, RuoxiSun, DongyuanWang, Xiaozeng